Laufey Amundadottir

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry
    Zhaoming Wang
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Hum Genet 131:1173-85. 2012
  2. ncbi Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels
    Hemang Parikh
    Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20877, USA
    Hum Genet 129:675-85. 2011
  3. ncbi Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer
    Xiaohong R Yang
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA
    Fam Cancer 10:545-8. 2011
  4. ncbi Detectable clonal mosaicism and its relationship to aging and cancer
    Kevin B Jacobs
    Division of Cancer Epidemiology and Genetics, National Cancer Institute NCI, Rockville, Maryland, USA
    Nat Genet 44:651-8. 2012
  5. ncbi A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33
    Hemang Parikh
    Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Gaithersburg, MD 20877, USA
    Hum Genet 127:91-9. 2010
  6. ncbi Assessing disease risk in genome-wide association studies using family history
    Arpita Ghosh
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA
    Epidemiology 23:616-22. 2012
  7. ncbi Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study
    Julia Ciampa
    Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, USA
    Cancer Res 71:3287-95. 2011

Collaborators

Detail Information

Publications7

  1. ncbi Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry
    Zhaoming Wang
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Hum Genet 131:1173-85. 2012
    ....
  2. ncbi Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels
    Hemang Parikh
    Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20877, USA
    Hum Genet 129:675-85. 2011
    ..12 ng/ml, 95% CI = 0.96-1.28) (P = 9.70 × 10(-5)). Together our results suggest that germline KLK3 variants could influence the diagnosis of nonaggressive prostate cancer by influencing the likelihood of biopsy...
  3. ncbi Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer
    Xiaohong R Yang
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA
    Fam Cancer 10:545-8. 2011
    ..The results suggested that PALB2 does not explain the relationship between CDKN2A, melanoma, and pancreatic cancer in these melanoma-prone families...
  4. ncbi Detectable clonal mosaicism and its relationship to aging and cancer
    Kevin B Jacobs
    Division of Cancer Epidemiology and Genetics, National Cancer Institute NCI, Rockville, Maryland, USA
    Nat Genet 44:651-8. 2012
    ..4; P = 3.8 × 10(-11)). These findings underscore the time-dependent nature of somatic events in the etiology of cancer and potentially other late-onset diseases...
  5. ncbi A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33
    Hemang Parikh
    Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Gaithersburg, MD 20877, USA
    Hum Genet 127:91-9. 2010
    ....
  6. ncbi Assessing disease risk in genome-wide association studies using family history
    Arpita Ghosh
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA
    Epidemiology 23:616-22. 2012
    ....
  7. ncbi Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study
    Julia Ciampa
    Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, USA
    Cancer Res 71:3287-95. 2011
    ..Overall, the interactions we have identified merit follow-up study, particularly the EPAS1 interaction, which has implications not only in prostate cancer but also in other epithelial cancers that are associated with the 8q24 locus...